major depressive disorder
METHODS: Outpatients with DSM-III-R major depressive disorder and atypical       features (N = 108) were treated in a 10-week, double-blind, randomized,       controlled trial comparing acute-phase cognitive therapy or clinical management       plus either phenelzine sulfate or placebo.
METHODS:  @OBJECT$   @PREDICAT$  DSM-III-R  @SUBJECT$  and atypical       features (N = 108) were treated in a 10-week, double-blind, randomized,       controlled trial comparing acute-phase cognitive therapy or clinical management       plus either phenelzine sulfate or placebo.